Announcements Trials

Browse Landscape

Phase

Phase 2 9 Phase 1 7 Phase NA 4 Phase 3 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 12 Lymphoid 11 Breast 4 Myeloid 3 Plasma cell 2 Gastrointestinal 2 Tumor-Agnostic 1 Sarcoma 1 Dermatologic 1 Classical hematology 1

Conditions

Interventions

Temozolomide 33 Radiotherapy 32 pembrolizumab 18 Cyclophosphamide 18 Irinotecan 16 Gemcitabine 16 Doxorubicin 16 Nivolumab 11 Docetaxel 11 Sirolimus 10 Imatinib Mesylate 10 Ifosfamide 10 Filgrastim 10 Radiation 9 Bevacizumab 9 Vincristine 8 Carboplatin 8 pazopanib 7 Everolimus 7 temsirolimus 6 atezolizumab 6 Peripheral Blood Stem Cell Transplantation 6 Etoposide 6 fludarabine phosphate 5 Vorinostat 5 Specimen Handling 5 Radiotherapy, Conformal 5 PM 01183 5 Ipilimumab 5 Erlotinib Hydrochloride 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Mesna × Sarcoma × Clear all

NCT00093509 2014-09-01

MRI Sarcoma Non Invasive Thermometry

Duke University

Phase 1/2 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡